Insights
Market intelligence for people building medtech companies.
ScaleCraft Monthly — Spanish and EU medtech: what moved in regulation, funding, trials and tenders, what it means from someone who has sold into these systems, and a short closing note on care as a craft. Alongside it, longer analysis on the economics of scaling in regulated markets.
The performance-learning paradox in the age of AI — and what it means for how you develop your people
OECD research shows AI can boost task performance while employee skill stays flat. Here's what that performance-learning paradox means for how growing companies should design AI-enabled training and L&D.
ReadThe €3M wall in medtech — and the distributor economics that break through it
Most device companies don't stall because demand dries up. They stall because the distributor model that got them to €3M is the same one that caps them there. Here's the fix.
ReadScaleCraft Monthly
What moved in Spanish and European medtech — and what it actually means.
Once a month: regulation, funding, clinical investigations and tenders — named and sourced — my read on what matters, and a short closing note.
Done. Welcome.
I have just written to confirm it. The first letter arrives next month — and you can reply to any of them, they come straight to me.